301 related articles for article (PubMed ID: 22184943)
1. [The outbreaks of invasive meningococcal disease in the municipalities of Goleniów and Przybiernów in March 2009. Control measures taken in the outbreak area].
Gatalska M; Marcinkowska BE; Opiela R; Sygit M
Przegl Epidemiol; 2011; 65(3):429-32. PubMed ID: 22184943
[TBL] [Abstract][Full Text] [Related]
2. Outbreak of invasive meningococcal disease in Goleniow County, northwest Poland, March 2009.
Skoczyńska A; Wasko I; Kuch A; Gołebiewska A; Foryś M; Hryniewicz W
Euro Surveill; 2010 Aug; 15(34):. PubMed ID: 20807486
[No Abstract] [Full Text] [Related]
3. Epidemiology and meningococcal serogroup distribution in the United States.
Hershey JH; Hitchcock W
Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
[No Abstract] [Full Text] [Related]
4. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
[No Abstract] [Full Text] [Related]
5. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
Krizova P; Musilek M
Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
[TBL] [Abstract][Full Text] [Related]
6. Community cluster of meningococcal disease by Neisseria meningitidis serogroup C in Andalusia, Spain, March to May 2011.
Mayoral Cortés JM; Torres Butrón E; García Fernández M; Herrador Ortiz Z; Huarte Osakar S; Santos Luque R; Pérez Morilla E; Guillén Enriquez J
Euro Surveill; 2012 Sep; 17(36):20261. PubMed ID: 22971329
[TBL] [Abstract][Full Text] [Related]
7. Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis.
Pérez-Trallero E; Vicente D; Montes M; Cisterna R
Lancet; 2002 Sep; 360(9337):953. PubMed ID: 12354504
[No Abstract] [Full Text] [Related]
8. Meningococcal disease and prevention at the Hajj.
Borrow R
Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
[TBL] [Abstract][Full Text] [Related]
10. Invasive meningococcal disease associated with a very high case fatality rate in the North-West of Poland.
Skoczyńska A; Kadłubowski M; Knap J; Szulc M; Janusz-Jurczyk M; Hryniewicz W
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):230-5. PubMed ID: 16487304
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal disease: a review on available vaccines and vaccines in development.
Bröker M; Fantoni S
Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
[TBL] [Abstract][Full Text] [Related]
12. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
Krízová P; Musílek M; Kalmusová J
Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
[TBL] [Abstract][Full Text] [Related]
13. Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005.
Rouaud P; Perrocheau A; Taha MK; Sesboué C; Forgues AM; Parent du Châtelet I; Levy-Bruhl D
Euro Surveill; 2006 Jul; 11(7):178-81. PubMed ID: 16966800
[TBL] [Abstract][Full Text] [Related]
14. Neisseria meningitidis carriage during an outbreak of serogroup C disease.
Patrick DM; Champagne S; Goh SH; Arsenault G; Thomas E; Shaw C; Rahim T; Taha F; Bigham M; Dubenko V; Skowronski D; Brunham RC
Clin Infect Dis; 2003 Nov; 37(9):1183-8. PubMed ID: 14557962
[TBL] [Abstract][Full Text] [Related]
15. Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France.
Deghmane AE; Parent du Chatelet I; Szatanik M; Hong E; Ruckly C; Giorgini D; Lévy-Bruhl D; Alonso JM; Taha MK
J Infect Dis; 2010 Jul; 202(2):247-50. PubMed ID: 20515410
[TBL] [Abstract][Full Text] [Related]
16. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
Brooks R; Woods CW; Benjamin DK; Rosenstein NE
Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
[TBL] [Abstract][Full Text] [Related]
17. Optimizing protection against meningococcal disease.
Reisinger KS; Black S; Stoddard JJ
Clin Pediatr (Phila); 2010 Jun; 49(6):586-97. PubMed ID: 20089551
[TBL] [Abstract][Full Text] [Related]
18. MenACWY-CRM, a novel quadrivalent glycoconjugate vaccine against Neisseria meningitidis for the prevention of meningococcal infection.
Pace D
Curr Opin Mol Ther; 2009 Dec; 11(6):692-706. PubMed ID: 20072946
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of invasive meningococcal disease in the Czech Republic.
Kriz P
Euro Surveill; 2004 Nov; 9(11):37-9. PubMed ID: 15591689
[TBL] [Abstract][Full Text] [Related]
20. [Meningococcal disease in Africa--epidemiology and prevention].
Norheim G; Rosenqvist E; Aavitsland P; Caugant DA
Tidsskr Nor Laegeforen; 2000 Jun; 120(15):1735-9. PubMed ID: 10904659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
